Do tunneling nanotubes drive chemoresistance in solid tumors and other malignancies?
Biochemical Society Transactions · 2024
DOI: 10.1042/bst20231364 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemical Society Transactions, 2024. Verfasst von Akshat Sarkari und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, U.S.A. Hauptthemen laut MEDLINE: Neoplasms, Drug Resistance, Neoplasm, Cell Communication, Tumor Microenvironment. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Intercellular communication within the tumor microenvironment (TME) is essential for establishing, mediating, and synchronizing cancer cell invasion and metastasis. Cancer cells, individually and collectively, react at the cellular and molecular levels to insults from standard-of-care treatments used to treat patients with cancer. One form of cell communication that serves as a prime example of cellular phenotypic stress response is a type of cellular protrusion called tunneling nanotubes (TNTs). TNTs are ultrafine, actin-enriched contact-dependent forms of membrane protrusions that facilitate long distance cell communication through transfer of various cargo, including genetic materials, mitochondria, proteins, ions, and various other molecules. In the past 5–10 years, there has been a growing body of evidence that implicates TNTs as a novel mechanism of cell-cell communication in cancer that facilitates and propagates factors that drive or enhance chemotherapeutic resistance in a variety of cancer cell types. Notably, recent literature has highlighted the potential of TNTs to serve as cellular conduits and mediators of drug and nanoparticle delivery. Given that TNTs have also been shown to form in vivo in a variety of tumor types, disrupting TNT communication within the TME provides a novel strategy for enhancing the cytotoxic effect of existing chemotherapies while suppressing this form of cellular stress response. In this review, we examine current understanding of interplay between cancer cells occurring via TNTs, and even further, the implications of TNT-mediated tumor-stromal cross-talk and the potential to enhance chemoresistance. We then examine tumor microtubes, an analogous cell protrusion heavily implicated in mediating treatment resistance in glioblastoma multiforme, and end with a brief discussion of the effects of radiation and other emerging treatment modalities on TNT formation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, U.S.A.
- Graduate Faculty, Integrative Biology and Physiology Department, University of Minnesota, Minneapolis, MN, U.S.A.
ORCID-Profile: Emil Lou
Zitieren
APA
Sarkari, A., & Lou, E. (2024). Do tunneling nanotubes drive chemoresistance in solid tumors and other malignancies?. Biochemical Society Transactions. https://doi.org/10.1042/bst20231364
Vancouver
Sarkari A, Lou E. Do tunneling nanotubes drive chemoresistance in solid tumors and other malignancies?. Biochemical Society Transactions. 2024. doi:10.1042/bst20231364
BibTeX
@article{Sarkari2024,
author = {Sarkari, Akshat and Lou, Emil},
title = {Do tunneling nanotubes drive chemoresistance in solid tumors and other malignancies?},
journal = {Biochemical Society Transactions},
year = {2024},
doi = {10.1042/bst20231364}
}
EUVIMED